119 related articles for article (PubMed ID: 32171171)
21. Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems.
Wang XG; Ma SY; Chang JS; Shi R; Wang RL; Zhao P; Xia QY
Insect Sci; 2019 Dec; 26(6):983-990. PubMed ID: 30088341
[TBL] [Abstract][Full Text] [Related]
22. Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA.
Lundh M; Pluciñska K; Isidor MS; Petersen PSS; Emanuelli B
Mol Metab; 2017 Oct; 6(10):1313-1320. PubMed ID: 29031730
[TBL] [Abstract][Full Text] [Related]
23. Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy.
Rong Z; Gong X; Hulleman JD; Corey DR; Mootha VV
Transl Vis Sci Technol; 2020 Aug; 9(9):47. PubMed ID: 32934897
[TBL] [Abstract][Full Text] [Related]
24. Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System.
Moses C; Nugent F; Waryah CB; Garcia-Bloj B; Harvey AR; Blancafort P
Mol Ther Nucleic Acids; 2019 Mar; 14():287-300. PubMed ID: 30654190
[TBL] [Abstract][Full Text] [Related]
25. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
[TBL] [Abstract][Full Text] [Related]
26. PhiReX 2.0: A Programmable and Red Light-Regulated CRISPR-dCas9 System for the Activation of Endogenous Genes in
Machens F; Ran G; Ruehmkorff C; Meyer Auf der Heyde J; Mueller-Roeber B; Hochrein L
ACS Synth Biol; 2023 Apr; 12(4):1046-1057. PubMed ID: 37014634
[TBL] [Abstract][Full Text] [Related]
27. Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes.
Ho SM; Hartley BJ; Flaherty E; Rajarajan P; Abdelaal R; Obiorah I; Barretto N; Muhammad H; Phatnani HP; Akbarian S; Brennand KJ
Stem Cell Reports; 2017 Aug; 9(2):615-628. PubMed ID: 28757163
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of CRISPR Activator Systems for Overexpression of CB1 Receptors in Neurons.
Di Maria V; Moindrot M; Ryde M; Bono A; Quintino L; Ledri M
Front Mol Neurosci; 2020; 13():168. PubMed ID: 33013319
[TBL] [Abstract][Full Text] [Related]
29. A piggyBac-based toolkit for inducible genome editing in mammalian cells.
Schertzer MD; Thulson E; Braceros KCA; Lee DM; Hinkle ER; Murphy RM; Kim SO; Vitucci ECM; Calabrese JM
RNA; 2019 Aug; 25(8):1047-1058. PubMed ID: 31101683
[TBL] [Abstract][Full Text] [Related]
30. [The Efficiency of Gene Activation Using CRISPR/dCas9-Based Transactivation Systems Depends on the System Run Time].
Artyuhov AS; Dorovskiy DA; Sorokina AV; Shakirova KM; Momotyuk ED; Dashinimaev EB
Mol Biol (Mosk); 2022; 56(6):1014-1022. PubMed ID: 36475485
[TBL] [Abstract][Full Text] [Related]
31. Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.
Balboa D; Weltner J; Eurola S; Trokovic R; Wartiovaara K; Otonkoski T
Stem Cell Reports; 2015 Sep; 5(3):448-59. PubMed ID: 26352799
[TBL] [Abstract][Full Text] [Related]
32. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems.
Papikian A; Liu W; Gallego-Bartolomé J; Jacobsen SE
Nat Commun; 2019 Feb; 10(1):729. PubMed ID: 30760722
[TBL] [Abstract][Full Text] [Related]
33. Optimized strategy for in vivo Cas9-activation in
Ewen-Campen B; Yang-Zhou D; Fernandes VR; González DP; Liu LP; Tao R; Ren X; Sun J; Hu Y; Zirin J; Mohr SE; Ni JQ; Perrimon N
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9409-9414. PubMed ID: 28808002
[TBL] [Abstract][Full Text] [Related]
34. Cellular reprogramming with multigene activation by the delivery of CRISPR/dCas9 ribonucleoproteins via magnetic peptide-imprinted chitosan nanoparticles.
Lee MH; Lin CC; Thomas JL; Li JA; Lin HY
Mater Today Bio; 2021 Jan; 9():100091. PubMed ID: 33521619
[TBL] [Abstract][Full Text] [Related]
35. Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae.
Deaner M; Mejia J; Alper HS
ACS Synth Biol; 2017 Oct; 6(10):1931-1943. PubMed ID: 28700213
[TBL] [Abstract][Full Text] [Related]
36. A CRISPR Interference System for Efficient and Rapid Gene Knockdown in Caulobacter crescentus.
Guzzo M; Castro LK; Reisch CR; Guo MS; Laub MT
mBio; 2020 Jan; 11(1):. PubMed ID: 31937638
[TBL] [Abstract][Full Text] [Related]
37. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
Park JJ; Dempewolf E; Zhang W; Wang ZY
PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
[TBL] [Abstract][Full Text] [Related]
38. Inactive Cas9 blocks vitreous-induced expression of Mdm2 and proliferation and survival of retinal pigment epithelial cells.
Chen N; Hu Z; Yang Y; Han H; Lei H
Exp Eye Res; 2019 Sep; 186():107716. PubMed ID: 31278903
[TBL] [Abstract][Full Text] [Related]
39. Positional effects on efficiency of CRISPR/Cas9-based transcriptional activation in rice plants.
Gong X; Zhang T; Xing J; Wang R; Zhao Y
aBIOTECH; 2020 Jan; 1(1):1-5. PubMed ID: 36305003
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
